T1	Participants 696 737	42 women at one site underwent colposcopy
T2	Participants 651 682	841 women at risk for pregnancy
T3	Participants 739 871	Women were randomized to use the FemCap or Ortho All-Flex contraceptive diaphragm, both with 2% nonoxynol-9 spermicide, for 28 weeks
